Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-26 @ 2:42 PM
Ignite Modification Date:
2025-12-26 @ 2:42 PM
NCT ID:
NCT02503306
Brief Summary:
Primary Objective:
o To assess the change in percent of sexual attempts in which subjects are able to maintain an erection of sufficient duration to have successful intercourse between the run-in period and treatment period:
* The change in percent of sexual attempts in which subjects are able to insert the penis into the partner's vagina.
* The change in score on the erectile function (EF) domain of the International Index of Erectile Function (IIEF) questionnaire.
Secondary Objective:
o To evaluate the safety and tolerability of avanafil in patients with erectile dysfunction (ED).
Detailed Description:
The total study duration per patient will be up to 12 weeks, consisting of an 8-week treatment period and a 4-week run-in period.
Study:
NCT02503306
Study Brief:
Protocol Section:
NCT02503306